Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Actorif versus Rebif in relapsing-remitting multiple sclerosis
IRCT2013030512398N3Phase 3Completed
- Sponsor
- BioSun Pharmed
- Start
- Oct 2011
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of interferon beta-1a in multiple sclerosis (MS) (2 arms), sponsored by BioSun Pharmed. Started Oct 2011; status: completed.
02
Drugs
interferon beta-1a
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on IRCT2013030512398N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2013030512398N3.